Subscribe
shutterstock_1528056221_jhvephoto
JHVEphoto / Shutterstock.com
25 May 2023MedtechLiz Hockley

Split Fed Cir refutes Medtronic challenge to catheter patents

Medtronic prior art reference does not qualify, says Federal Circuit | Firm was hoping to invalidate five catheter technology patents.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Axonics v Medtronic: Fed Circ addresses PTAB ‘errors’
17 August 2023   A recent precedential case highlights the thorny issue of what constitutes a fair response to new claim constructions following an institution, says Blair Jacobs of McKool Smith.
Biotechnology
Teleflex inks $650m deal with Nordic pharma firm
27 July 2023   Swedish company’s products treat urologic disorders and colorectal conditions | Portfolio includes unique treatment for prostate cancer radiation therapy.
Big Pharma
Fed Circ sides with Axonics in patent validity battle
8 August 2023   US Court of Appeals highlights procedural rules in patent dispute concerning medical device charging patents | Medtronic now faces further patent validity reviews after Fed Circ rules in favour of rival.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

More on this story

Americas
Axonics v Medtronic: Fed Circ addresses PTAB ‘errors’
17 August 2023   A recent precedential case highlights the thorny issue of what constitutes a fair response to new claim constructions following an institution, says Blair Jacobs of McKool Smith.
Big Pharma
Fed Circ sides with Axonics in patent validity battle
8 August 2023   US Court of Appeals highlights procedural rules in patent dispute concerning medical device charging patents | Medtronic now faces further patent validity reviews after Fed Circ rules in favour of rival.
Biotechnology
Teleflex inks $650m deal with Nordic pharma firm
27 July 2023   Swedish company’s products treat urologic disorders and colorectal conditions | Portfolio includes unique treatment for prostate cancer radiation therapy.

More on this story

Americas
Axonics v Medtronic: Fed Circ addresses PTAB ‘errors’
17 August 2023   A recent precedential case highlights the thorny issue of what constitutes a fair response to new claim constructions following an institution, says Blair Jacobs of McKool Smith.
Big Pharma
Fed Circ sides with Axonics in patent validity battle
8 August 2023   US Court of Appeals highlights procedural rules in patent dispute concerning medical device charging patents | Medtronic now faces further patent validity reviews after Fed Circ rules in favour of rival.
Biotechnology
Teleflex inks $650m deal with Nordic pharma firm
27 July 2023   Swedish company’s products treat urologic disorders and colorectal conditions | Portfolio includes unique treatment for prostate cancer radiation therapy.

More features

Fed Circ orders Teva to delist five patents from Orange Book
Sarepta wins $115M in patent dispute over muscular dystrophy drug
Novartis shields eye-drop patent at European Patent Office
CREATES Act unfairly tips the scales to generics
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York